1. Hung, Chen-Ting, Su, Tung-Hung, Chen, Yen-Ting, Lin, Shuei-Liong, Yang, Kai-Chien. 2021. Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling. In Gut, 71, 1876-1891. doi:10.1136/gutjnl-2021-325065. https://pubmed.ncbi.nlm.nih.gov/34933915/
2. Zhang, Lin, Hou, Yanhong, Li, Nan, Wu, Kai, Zhai, Junshan. 2010. The influence of TXNDC5 gene on gastric cancer cell. In Journal of cancer research and clinical oncology, 136, 1497-505. doi:10.1007/s00432-010-0807-x. https://pubmed.ncbi.nlm.nih.gov/20157732/
3. Xu, Bing, Li, Jian, Liu, Xiaoxin, Li, Chang, Chang, Xiaotian. 2017. TXNDC5 is a cervical tumor susceptibility gene that stimulates cell migration, vasculogenic mimicry and angiogenesis by down-regulating SERPINF1 and TRAF1 expression. In Oncotarget, 8, 91009-91024. doi:10.18632/oncotarget.18857. https://pubmed.ncbi.nlm.nih.gov/29207620/
4. Zeng, Yanping, Ma, Weixing, Ma, Cheng, Ren, Xiaohui, Wang, Yan. 2021. Inhibition of TXNDC5 attenuates lipopolysaccharide-induced septic shock by altering inflammatory responses. In Laboratory investigation; a journal of technical methods and pathology, 102, 422-431. doi:10.1038/s41374-021-00711-5. https://pubmed.ncbi.nlm.nih.gov/34864825/
5. Zhang, Lin, Wu, Kai, Hou, Yanhong, Li, Xianghui. 2024. Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis. In Translational cancer research, 13, 81-101. doi:10.21037/tcr-23-904. https://pubmed.ncbi.nlm.nih.gov/38410208/
6. Park, Min-Su, Kim, Su Kang, Shin, Hyun Phil, Lee, Sang-Mok, Chung, Joo-Ho. . TXNDC5 gene polymorphism contributes to increased risk of hepatocellular carcinoma in the Korean male population. In Anticancer research, 33, 3983-7. doi:. https://pubmed.ncbi.nlm.nih.gov/24023338/
7. Chiu, Hsun-I, Wu, Shi-Bei, Wu, Albert Y, Tsai, Chieh-Chih. 2024. Endoplasmic reticulum protein TXNDC5 modulates thyroid eye disease TGF-β1-induced myofibroblast transdifferentiation. In BMJ open ophthalmology, 9, . doi:10.1136/bmjophth-2024-001693. https://pubmed.ncbi.nlm.nih.gov/39721966/
8. Chang, Cunjie, Rajasekaran, Muthukumar, Qiao, Yiting, Hui, Kam Man, Chen, Jianxiang. 2022. The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma. In Nature communications, 13, 1363. doi:10.1038/s41467-022-29016-x. https://pubmed.ncbi.nlm.nih.gov/35296659/
智鼠故事 
